Markup of Ten Pieces of Legislation

Health Care Costs and Drug PricingHouse Energy and Commerce Subcommittee on Health · 2026-05-13 · 119th Congress
The House Energy and Commerce Subcommittee on Health met to mark up ten bipartisan bills covering public health program reauthorizations, FDA authorities, and Medicare payment changes, including tick-borne disease research, breast cancer education, ALS therapies, stem cell transplants, school-based health centers, hazardous import destruction, animal-free drug testing, and wheelchair and accountable care organization reporting rules. Begins at 0:13:44
Transcript
Highlights

Title

Markup of ten bipartisan health bills, including tick, ALS, and Alzheimer's reauthorizations

Purpose

The House Energy and Commerce Subcommittee on Health met to mark up ten bipartisan bills covering public health program reauthorizations, FDA authorities, and Medicare payment changes, including tick-borne disease research, breast cancer education, ALS therapies, stem cell transplants, school-based health centers, hazardous import destruction, animal-free drug testing, and wheelchair and accountable care organization reporting rules. Ranking Member DeGette used her opening statement to criticize the majority for holding only its second subcommittee markup this Congress and for not addressing ACA subsidy expiration, NIH funding cuts, and rural hospital Medicaid cuts. Begins at0:13:44

Who spoke

Chairman Morgan Griffith (R-VA)0:13:44: Opened by outlining the ten bills, including the Kay Hagan Tick Act reauthorization0:14:30 and the ACT for ALS reauthorization0:14:55; later led several bills himself, including the Kay Hagan Tick Act0:31:40 and the Health Care Efficiency Through Flexibility Act amendment2:15:40, and noted his own experience with alpha-gal syndrome from tick bites0:33:31.

Rep. Diana DeGette (D-CO), Ranking Member0:17:11: Supported all ten bills but criticized the pace of subcommittee work, noting only two markups this Congress versus five by this point in the 118th0:18:43; cited 20% fewer ACA exchange enrollees and 80% reporting higher costs due to expiring enhanced tax credits0:19:22, and spoke in support of the Kay Hagan Tick Act0:34:00.

Rep. Brett Guthrie (R-KY), Full Committee Chairman0:21:39: Highlighted programs fighting vector-borne diseases, ALS treatments, and school-based health centers0:22:32, and described the port-shopping crackdown bill for FDA enforcement0:23:19.

Rep. Frank Pallone (D-NJ), Full Committee Ranking Member0:24:16: Criticized Trump administration public health leadership, citing NIH grant funding down 44% in FY2026 versus the 2021–24 average0:25:22 and the FDA commissioner's resignation the prior day0:25:44; supported the School-Based Health Centers Reauthorization Act0:26:13 and the ACT for ALS Act0:27:11.

Rep. Raul Ruiz (D-CA)0:28:39: Spoke as an emergency physician about patients from underserved communities delaying care0:29:19, citing that community health centers serve 18% of California's kids while nearly 30% miss preventive checkups0:30:13; voiced support for H.R. 8209, the School-Based Health Centers Reauthorization Act0:30:13.

Rep. Kim Schrier (D-WA)0:35:33: Said tick-borne disease cases have risen 25-fold since 19820:36:24 and described expanding tick habitats in Washington state due to climate change0:35:59; later cited over 70 school-based health centers in Washington providing nearly 17,000 visits0:51:11, and was noted as a cosponsor of the wheelchair bill2:23:38.

Rep. Troy Balderson (R-OH)0:39:44: Introduced the amendment in the nature of a substitute to H.R. 3747 (ADAPT Act), citing over 7 million Americans, including 236,000 Ohioans, with Alzheimer's0:40:36; also spoke for the School-Based Health Centers Reauthorization Act, noting over 2,500 centers serving 6.3 million K-12 students nationwide0:48:34.

Rep. Nanette Barragán (D-CA)0:42:29: Supported the ADAPT Act but criticized removal of targeted Alzheimer's/dementia funding from the original bill, citing $409 billion in current Alzheimer's costs projected to near $1 trillion by 20500:42:56; shared her experience as a caregiver for her mother with Alzheimer's0:43:23; also co-led H.R. 2821, the FDA Modernization Act 3.02:13:34.

Rep. John Joyce (R-PA)0:45:35: Spoke in support of the ADAPT Act's Project ECHO grants for rural primary care providers0:46:01; later introduced the amendment in the nature of a substitute to H.R. 1703, the Choices for Increased Mobility Act, describing a 2016 policy barring beneficiaries from paying the difference for titanium/carbon fiber wheelchairs2:20:49.

Rep. Gus Bilirakis (R-FL)0:53:12: Spoke for H.R. 5160, the Stem Cell Therapeutic and Research Reauthorization Act, describing the C.W. Bill Young Cell Transplantation Program and National Cord Blood Inventory0:54:07; also spoke for H.R. 8205, the ALS therapies reauthorization through fiscal year 20310:56:17.

Rep. Buddy Carter (R-GA)0:59:20: Introduced the amendment in the nature of a substitute to H.R. 2715, the Destruction of Hazardous Imports Act, describing "port shopping" by foreign exporters of contaminated seafood and counterfeit drugs1:01:08; later spoke for H.R. 2821, the FDA Modernization Act 3.0, on reducing animal testing2:11:07.

Key moments

DeGette said 20% fewer people are enrolled in ACA exchanges and 80% of enrollees report higher health care costs due to expiring enhanced tax credits, calling this the majority's "bare minimum"0:19:22.

Pallone cited NIH biomedical grant funding down 44% in FY2026 compared to the 2021–24 average and noted FDA Commissioner Mike Carey's resignation "amid chaos, confusion, potential corruption" the day before the markup0:25:220:25:44.

Barragán disclosed that 69% of primary care providers report little to no dementia training in medical school and 39% lack confidence to diagnose it, illustrating with her own mother's misdiagnosis experience0:43:480:44:19.

Balderson's amendment to H.R. 3747 (ADAPT Act) removed targeted Alzheimer's/dementia funding from the original bill, a change Barragán said she supported the bill despite disagreeing with0:42:29.

Carter said Chinese exporters have been caught resubmitting FDA-rejected shipments at different ports, a practice called "port shopping," which H.R. 2715 aims to close by letting FDA order destruction of hazardous imports1:01:081:02:05.

Joyce's amendment to H.R. 1703 would create two new wheelchair billing codes so Medicare Part B beneficiaries can pay out-of-pocket for titanium or carbon fiber wheelchair upgrades, reversing a 2016 policy that made full out-of-pocket purchase the only option2:20:492:21:50.

Schrier said tick-borne disease cases have increased 25-fold since 1982 and that ticks are now appearing in new areas like Washington's Issaquah Alps and Olympic Peninsula due to climate change0:35:590:36:24.

All ten bills were forwarded to the full committee by voice vote with no recorded opposition, including H.R. 4348 (Kay Hagan Tick Act)0:37:17, H.R. 4541 (EARLY Act)0:38:15, H.R. 3747 as amended (ADAPT Act)0:47:19, H.R. 8209 (school-based health centers)0:52:19, H.R. 5160 (stem cell research)0:55:50, H.R. 8205 (ALS therapies)0:58:31, H.R. 2715 as amended (hazardous imports)1:03:23, H.R. 2821 (FDA Modernization 3.0)2:14:42, H.R. 5347 as amended (ACO reporting flexibility)2:19:12, and H.R. 1703 as amended (wheelchair choices)2:23:38.

The markup recessed after five bills for a five-vote House floor series, resuming roughly 67 minutes later to complete the final three bills1:03:522:10:37.

Metadata

CommitteeHouse Energy and Commerce Subcommittee on Health
Chamber / CongressHouse · 119th Congress
Date2026-05-13
TypeMarkup
Witnesses
(none listed in event metadata)
Videoyoutube
Transcript148 caption blocks · 9,846 words · 2:24:21 runtime
EventCongress.gov 119294